Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-029747

CHIEF OPERATING OFFICER sold 23,017 shares at $20.44 ($470,467)

  • CHIEF OPERATING OFFICER acquired 16,017 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tessari Eben CHIEF OPERATING OFFICER 2024-12-16 Option exercise 10b5-1 +16,017 $1.59 $25,467 118,992 D
Tessari Eben CHIEF OPERATING OFFICER 2024-12-16 Sale 10b5-1 −23,017 $20.44 $470,467 95,975 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2024-12-16 Option exercise · Share Option 10b5-1 −16,017 0 D
Open-market sales · 23,017 sh · avg $20.44 · $470,467
Loading xslF345X05/form4-12182024_091234.xml…